ResMed Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $414.1M | $351.8M | $62.2M | $45.9M |
| FY2018 | $505.0M | $442.4M | $62.6M | $48.4M |
| FY2019 | $459.1M | $390.3M | $68.7M | $52.1M |
| FY2020 | $802.3M | $706.9M | $95.3M | $57.6M |
| FY2021 | $736.7M | $634.0M | $102.7M | $63.9M |
| FY2022 | $351.1M | $216.3M | $134.8M | $65.3M |
| FY2023 | $693.3M | $573.6M | $119.7M | $71.1M |
| FY2024 | $1.40B | $1.30B | $99.5M | $80.2M |
| FY2025 | $1.75B | $1.66B | $89.9M | $91.7M |
| FY2026 | $1.81B | $1.65B | $156.3M | $104.3M |